Comparative Efficacy Safety and Discontinuation of Inhaled Levodopa for Patients With Parkinson&#39;s Disease: A Network Meta-Analysis

Inbrija (levodopa inhalation powder) - Merz Pharma

https://www.ispor.org/conferences-education/conferences/upcoming-conferences/ispor-europe-2025/program/program/paper/ispor-europe-2025/poster-session-2-2/comparative-efficacy-safety-and-discontinuation-of-inhaled-levodopa-for-patients-with-parkinson-s-disease-a-network-meta-analysis

Ubong Silas, MSc 1; Omar Madani, MSc 2; Chetan Mistry, MSc 2; Rushab Shah, BSc 2; Grace Chattey, MSc 2; Leandro Guerra Primo, MSc 3; Stefano Perni, PhD 2.

Nov 11, 2025